JP2024512978A5 - - Google Patents
Info
- Publication number
- JP2024512978A5 JP2024512978A5 JP2023559686A JP2023559686A JP2024512978A5 JP 2024512978 A5 JP2024512978 A5 JP 2024512978A5 JP 2023559686 A JP2023559686 A JP 2023559686A JP 2023559686 A JP2023559686 A JP 2023559686A JP 2024512978 A5 JP2024512978 A5 JP 2024512978A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- immune cell
- container
- cell population
- additive composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20210040926 | 2021-03-30 | ||
| KR10-2021-0040926 | 2021-03-30 | ||
| PCT/KR2022/004509 WO2022211491A1 (ko) | 2021-03-30 | 2022-03-30 | 면역세포 조성물을 생산하는 방법 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024512978A JP2024512978A (ja) | 2024-03-21 |
| JP2024512978A5 true JP2024512978A5 (enExample) | 2025-04-03 |
Family
ID=83459472
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023559686A Pending JP2024512978A (ja) | 2021-03-30 | 2022-03-30 | 免疫細胞組成物を生成するための方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20240181053A1 (enExample) |
| EP (1) | EP4317423B1 (enExample) |
| JP (1) | JP2024512978A (enExample) |
| KR (2) | KR102666931B1 (enExample) |
| WO (1) | WO2022211491A1 (enExample) |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20120244133A1 (en) * | 2011-03-22 | 2012-09-27 | The United States of America, as represented by the Secretary, Department of Health and | Methods of growing tumor infiltrating lymphocytes in gas-permeable containers |
| JOP20190224A1 (ar) * | 2017-03-29 | 2019-09-26 | Iovance Biotherapeutics Inc | عمليات من أجل إنتاج الخلايا اللمفاوية المرتشحة للأورام واستخداماتها في العلاج المناعي |
| WO2019136459A1 (en) * | 2018-01-08 | 2019-07-11 | Iovance Biotherapeutics, Inc. | Processes for generating til products enriched for tumor antigen-specific t-cells |
| CA3094957A1 (en) * | 2018-03-29 | 2019-10-03 | Iovance Biotherapeutics, Inc. | Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy |
| WO2019210131A1 (en) * | 2018-04-27 | 2019-10-31 | Iovance Biotherapeutics, Inc. | Closed process for expansion and gene editing of tumor infiltrating lymphocytes and uses of same in immunotherapy |
| WO2019217753A1 (en) * | 2018-05-10 | 2019-11-14 | Iovance Biotherapeutics, Inc. | Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy |
| WO2020096927A1 (en) * | 2018-11-05 | 2020-05-14 | Iovance Biotherapeutics, Inc. | Expansion of tils utilizing akt pathway inhibitors |
| KR20200092155A (ko) * | 2019-01-24 | 2020-08-03 | 울산대학교 산학협력단 | 종양침윤림프구를 유효성분으로 포함하는 삼중음성 유방암 예방 또는 치료용 조성물 |
| WO2020232029A1 (en) * | 2019-05-13 | 2020-11-19 | Iovance Biotherapeutics, Inc. | Methods and compositions for selecting tumor infiltrating lymphocytes and uses of the same in immunotherapy |
| CN110938594A (zh) * | 2019-09-12 | 2020-03-31 | 夏建川 | 一种功能增强型til细胞的培养方法 |
-
2022
- 2022-03-30 KR KR1020220039335A patent/KR102666931B1/ko active Active
- 2022-03-30 EP EP22781610.5A patent/EP4317423B1/en active Active
- 2022-03-30 JP JP2023559686A patent/JP2024512978A/ja active Pending
- 2022-03-30 US US18/285,135 patent/US20240181053A1/en active Pending
- 2022-03-30 WO PCT/KR2022/004509 patent/WO2022211491A1/ko not_active Ceased
-
2024
- 2024-04-23 KR KR1020240053740A patent/KR20240078405A/ko active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20230323298A1 (en) | Gammadelta t cell expansion procedure | |
| Klapper et al. | Single-pass, closed-system rapid expansion of lymphocyte cultures for adoptive cell therapy | |
| US11160830B2 (en) | Activation of marrow infiltrating lymphocytes in hypoxic alternating with normoxic conditions | |
| JP2021503281A5 (enExample) | ||
| CN115369086B (zh) | 一种nk细胞扩大培养的培养方案 | |
| CN108624559B (zh) | 无饲养层体外扩增原代nk细胞的培养组合物及其应用 | |
| JP2020515257A5 (enExample) | ||
| CN109337870B (zh) | 人Vγ9Vδ2T细胞扩增方法与培养基 | |
| Albrecht et al. | Generation of colon cancer–derived tumor-infiltrating T cells (TILs) for adoptive cell therapy | |
| CN116240168A (zh) | Nk细胞的制备及其应用 | |
| CN116024169A (zh) | 肿瘤浸润淋巴细胞的培养方法 | |
| Shimizu et al. | Clonal analysis of tumor‐infiltrating lymphocytes from human primary and metastatic liver tumors | |
| EP2878666A1 (en) | Industrial preparation of natural killer cells (nks) and injection using human allogeneic karyocytes | |
| CN109593717A (zh) | 一种干细胞无血清培养基 | |
| IL293874B2 (en) | Improved process for culturing tumor-infiltrating lymphocytes for therapeutic use | |
| Stroncek et al. | Developments in clinical cell therapy | |
| JP2024512978A5 (enExample) | ||
| US20230295566A1 (en) | Method for producing tumor-infiltrating t-lymphocytes (til) and their use as cellular therapeutics for the treatment of human tumors | |
| Wang et al. | Cytotoxicity of cord blood derived Her2/neu-specific cytotoxic T lymphocytes against human breast cancer in vitro and in vivo | |
| US20260102491A1 (en) | Method for in vitro large-scale expansion of double-negative t cells rich in tscm and tcm | |
| CN108456658A (zh) | 促进造血干细胞扩增并抑制其分化的化合物及细胞因子组合物 | |
| CN117427158A (zh) | 奈非那韦联合免疫检查点抑制剂在制备抗肿瘤药物中的应用 | |
| Mu et al. | Case Report: Cord blood-derived natural killer cells as new potential immunotherapy drug for solid tumor: A case study for endometrial cancer | |
| CN103160464A (zh) | 一种快速增殖效应淋巴细胞的制备方法及其试剂盒、用途 | |
| CN102813916A (zh) | 一种快速获取树突状细胞疫苗的制备方法及其应用 |